Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/16/2008WO2008124577A1 Renin inhibitors
10/16/2008WO2008124575A1 Renin inhibitors
10/16/2008WO2008124550A1 Phenothiazin derivatives for antiviral treatments
10/16/2008WO2008124532A1 Quinazolinone derivatives as aldh-2 inhibitors
10/16/2008WO2008124524A2 Aryl sulfonamide compounds as modulators of the cck2 receptor
10/16/2008WO2008124518A1 Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor
10/16/2008WO2008124505A2 Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
10/16/2008WO2008124496A1 Method of treating acid-sensing ion channel mediated pain, cough, and central nervous system disorders
10/16/2008WO2008124491A1 Pyrazinoylguanidine compounds for use taste modulators
10/16/2008WO2008124467A1 Bifunctional hydroxamic acid ligands and method of synthesis
10/16/2008WO2008124393A1 Benzothiazole derivatives and their use as protein kinase inhibitors
10/16/2008WO2008124323A1 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/16/2008WO2008124300A1 Hepatitis c virus inhibitors
10/16/2008WO2008124210A1 Methods and compositions for treating or preventing infection using leukocyte sequestration agents
10/16/2008WO2008124209A1 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
10/16/2008WO2008124192A2 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections
10/16/2008WO2008124184A1 Treatment of headaches, neck pain, joint pain and inflammatory-type pain
10/16/2008WO2008124170A2 SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES
10/16/2008WO2008124161A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
10/16/2008WO2008124157A1 Carbocyclic compounds and methods for treating emerging diseases, including influenza and venezuela equine encephalitis virus
10/16/2008WO2008124153A1 Heteroaryl amide analogues as p2x7 antagonists
10/16/2008WO2008124151A2 Use of creatine compounds for the treatment of eye disorders
10/16/2008WO2008124150A1 Method of treating enteritis, intestinal damage, and diarrhea from c. difficile with an a2a adenosine receptor agonist
10/16/2008WO2008124145A1 Steroid compounds, compositions, and methods of treatment
10/16/2008WO2008124143A1 Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists
10/16/2008WO2008124132A1 Chirally pure isomers of itraconazole and inhibitors of lanosterol 14a- demethylase for use as angiogenesis inhibitors
10/16/2008WO2008124131A1 Antifungal agents as neuroprotectants
10/16/2008WO2008124129A2 Treating hiv with a m-csf effector kinase inhibitor like imatinib
10/16/2008WO2008124128A2 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
10/16/2008WO2008124126A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo
10/16/2008WO2008124125A1 Anti-tumor activity of temsirolimus in papillary renal cell cancer
10/16/2008WO2008124122A1 Combinations of statins and anti-obesity agent and glitazones
10/16/2008WO2008124121A1 Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
10/16/2008WO2008124120A1 Combinations of statins and anti-obesity agent
10/16/2008WO2008124097A2 Salts of isophosphoramide mustard and analogs thereof
10/16/2008WO2008124088A2 Compositions and methods for the treatment of heart failure
10/16/2008WO2008124083A2 Aurora kinase modulators and method of use
10/16/2008WO2008124075A1 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
10/16/2008WO2008124072A1 Palmerolides: methods of preparation and derivatives thereof
10/16/2008WO2008124055A1 Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
10/16/2008WO2008124030A1 Therapeutic agents
10/16/2008WO2008124026A1 Wortmannin-rapamycin conjugate and uses thereof
10/16/2008WO2008124020A1 Wortmannin-rapalog conjugate and uses thereof
10/16/2008WO2008124009A2 Treating glaucoma
10/16/2008WO2008124000A2 Thiazole derivatives as androgen receptor modulator compounds
10/16/2008WO2008123963A1 Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
10/16/2008WO2008123953A1 Anti-hypercholesterolemic compound
10/16/2008WO2008123914A1 Crystalline forms i and ii of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
10/16/2008WO2008123891A1 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/16/2008WO2008123821A1 4, 5-dihydro-lh-imidazol-2-amine derivatives for use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
10/16/2008WO2008123800A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles
10/16/2008WO2008123798A1 Solid nanocomposition for delivering biologically active substances
10/16/2008WO2008123797A1 Nanoemulsion with biologically active agents
10/16/2008WO2008123796A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof
10/16/2008WO2008123759A1 N-sulphoethylnicotinamide, pharmaceutical compositions containing same and use thereof for inhibiting or preventing unwanted formation of fibrous tissue
10/16/2008WO2008123758A1 Pharmaceutical composition comprising n-sulphoethylnicotinamide useful in treatment or prevention of a pulmonary disease and use of said composition for treatment or prevention of said disease
10/16/2008WO2008123756A1 A pharmaceutical compositions containing lacton type pyridine derivatives as an effective ingredient for the prevention and treatment of ischemia
10/16/2008WO2008123755A1 A pharmaceutical compositions containing lactam type pyridine derivatives as an effective ingredient for the prevention and treatment of ischemia
10/16/2008WO2008123701A1 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
10/16/2008WO2008123684A1 Use of agmatine for protection of retinal ganglion cells
10/16/2008WO2008123639A1 Nano platinum ginsenoside particle and production method thereof
10/16/2008WO2008123625A1 Method for activating receptor by cofactor and method for utilizing ligand activity
10/16/2008WO2008123602A1 Therapeutic agent for arthropathy for intraarticular administration
10/16/2008WO2008123592A1 A medicament for treating schizophrenia comprising cilostazol
10/16/2008WO2008123582A1 Tetrahydroisoquinoline compound
10/16/2008WO2008123536A1 Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
10/16/2008WO2008123471A1 Composition for cleaning nasal fossa
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123396A1 Suspension-type eye drop preparation comprising fluorometholone
10/16/2008WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
10/16/2008WO2008123298A1 Infusion preparation for cancer patient
10/16/2008WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008123202A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR
10/16/2008WO2008123102A1 Anti-viral agent
10/16/2008WO2008123093A1 Agent for prevention or treatment of iron overload
10/16/2008WO2008123017A1 Novel diamide derivative
10/16/2008WO2008122994A2 Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
10/16/2008WO2008122810A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008WO2008122798A2 Pharmaceutical composition of an eg5 inhibitor and a microtubule interfering agent for the treatment of cancer
10/16/2008WO2008122794A2 Breast cancer methods, medicaments and agents
10/16/2008WO2008122784A1 Quinolines and their therapeutic use
10/16/2008WO2008122779A1 Combination of a purine-based cdk inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders
10/16/2008WO2008122767A2 2, 6, 9-substituted purine derivatives having anti proliferative properties
10/16/2008WO2008122765A1 New compounds and their uses 707
10/16/2008WO2008122741A1 Conjugated fatty acids and poly-l-lysine for combating pathogenic micro-organisms
10/16/2008WO2008122723A2 Use of poly-unsaturated fatty acids and flavonoids as active ingredients in a composition for preventing and/or treating migraines
10/16/2008WO2008122666A1 Inhibitors of mrp4 for the treatment of vascular disorders
10/16/2008WO2008122638A2 Process for preparing pramipexole dihydrochloride tablets
10/16/2008WO2008122620A1 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerisation
10/16/2008WO2008122618A1 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
10/16/2008WO2008122615A1 [2, 6] naphthyridines useful as protein kinase inhibitors
10/16/2008WO2008122614A1 2, 6-naphthyridine derivatives as protein kinase modulators
10/16/2008WO2008122561A1 Pyridinone derivative for the treatment of premature ejaculation
10/16/2008WO2008122546A1 Prolinamide derivatives as modulators of voltage-gated sodium channels
10/16/2008WO2008122513A1 Heterocycles as orexin antagonists
10/16/2008WO2008122510A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
10/16/2008WO2008122440A2 Remedy for the treatment of cardio-vascular diseases or disorders
10/16/2008WO2008122439A2 Dr0spiren0ne/17beta-estradi0l regimen, pharmaceutical combination product and kit for performing this regimen
10/16/2008WO2008122415A1 Stable aqueous g-csf formulations
1 ... 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 ... 7860